Reardon Tighe

Average Profitability
1.61%
Insider Buys Quantity
2
Insider Buys Sum
$15.69M
Insider Sells Quantity
1
Insider Sells Sum
$45.04M

Insider Activity of Reardon Tighe

According to the SEC Form 4 filings, Reardon Tighe, being in a position of

  1. Acting Chief Financial Officer at Janux Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 822721 share for $45.04M,
    over all time since 2021-06-15, has bought 1479265 shares for $15.69M, and sold 822721 share for $45.04M.

The largest purchase of all time was on 2021-06-15 and amounted to 629411 share of Janux Therapeutics, Inc. for $10.7M.

The largest sale of all time was on 2024-06-03 and amounted to 822721 share of Janux Therapeutics, Inc. for $45.04M.

Biography of Reardon Tighe

No biography is available at this moment.

2024-06-03SaleJanux Therapeutics, Inc.
JANX
Acting Chief Financial Officer
822,721
1.5801%
$54.75$45.04M-18.26%
2023-11-13PurchaseJanux Therapeutics, Inc.
JANX
Acting Chief Financial Officer
849,854
1.538%
$5.87$4.99M+489.34%
2021-06-15PurchaseJanux Therapeutics, Inc.
JANX
Acting Chief Financial Officer
629,411
5.7397%
$17.00$10.7M+1.61%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.